The autologous cell therapy market is undergoing a transformative phase, driven by advancements in precision medicine and technology. Valued at approximately USD 7.8
The autologous cell therapy market is undergoing a transformative phase, driven by advancements in precision medicine and technology. Valued at approximately USD 7.8